Pain Research, Informatics, Multimorbidities, and Education (PRIME) Center, VA Connecticut Healthcare System, West Haven, Connecticut.
Departments of Urology.
Pain Med. 2018 Sep 1;19(suppl_1):S12-S18. doi: 10.1093/pm/pny125.
Opioid misuse is a significant public health problem. As initial exposures to opioids are frequently encountered through the management of postoperative pain, we examined patterns of opioid prescribing following surgical treatment for nephrolithiasis.
We identified patients with nephrolithiasis in the national Women Veterans Cohort Study (WVCS) who were treated surgically by diagnosis and procedure codes. Using standard conversion factors, we calculated the morphine milligram equivalent (MME) dose prescribed. We used descriptive statistics to characterize opioid prescription across management strategy and multivariable regression to examine clinical and demographic characteristics associated with dispensed dose.
We identified 22,609 patients diagnosed with kidney stones during 1999-2014, 1,976 of whom were treated surgically and 1,582 (80.1%) of whom received an opioid prescription. The median age was 39 years, and 1,366 (90%) were male; 1,314 (86.3%) were treated with ureteroscopy, 172 (11.3%) with extracorporeal shockwave lithotripsy, and 36 (2.4%) with percutaneous nephrolithotomy. The median number of days supplied per opioid prescription (interquartile range) was 10 (5-14), and patients were dispensed a median of 180 (140-300) MME. A total of 6.4% of patients received ≥50 MME/d. On multivariable analysis, comorbid diagnosis of post-traumatic stress disorder (PTSD) was associated with higher total dispensed dose, whereas surgery type was not.
We observed substantial variation in opioid prescribing following surgical treatment of nephrolithiasis. Although type of surgical intervention did not impact opioid dosing, patients with a diagnosis of PTSD were more likely to receive higher doses. This work can inform efforts to improve the safety and efficacy of postoperative opioid prescribing.
阿片类药物滥用是一个重大的公共卫生问题。由于术后疼痛管理中经常会初次接触到阿片类药物,因此我们研究了肾结石治疗后阿片类药物的开具情况。
我们在全国女性退伍军人队列研究(WVCS)中确定了肾结石患者,他们通过诊断和手术代码接受了手术治疗。我们使用标准的转换系数计算了开具的吗啡毫克当量(MME)剂量。我们使用描述性统计方法来描述各种管理策略下的阿片类药物处方,并使用多变量回归来研究与配发剂量相关的临床和人口统计学特征。
我们在 1999 年至 2014 年间确定了 22609 例肾结石患者,其中 1976 例接受了手术治疗,1582 例(80.1%)患者开具了阿片类药物处方。患者的中位年龄为 39 岁,其中 1366 例(90%)为男性;1314 例(86.3%)接受了输尿管镜检查,172 例(11.3%)接受了体外冲击波碎石术,36 例(2.4%)接受了经皮肾镜碎石术。阿片类药物处方供应的中位天数(四分位间距)为 10(5-14)天,患者配发的中位数为 180(140-300)MME。共有 6.4%的患者接受了≥50MME/d 的治疗。多变量分析显示,患有创伤后应激障碍(PTSD)的合并症与总配发剂量较高相关,而手术类型则没有。
我们观察到肾结石手术后阿片类药物的开具情况存在很大差异。尽管手术干预的类型并未影响阿片类药物的剂量,但患有 PTSD 的患者更有可能接受更高剂量的药物。这项工作可以为改善术后阿片类药物处方的安全性和有效性提供参考。